跳至主要内容
临床试验/NCT04808375
NCT04808375Unknown不适用

Risk Factors for Pregnancy-induced Hypertension in Pregnant Patients Undergoing Cesarean Section: a Retrospective Study

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2021年3月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,200
试验地点
1
主要终点
Adverse maternal outcomes

研究概览

简要总结

After Institutional Review Board approval, we performed a retrospective cohort study among all women presenting for pregnancy-induced hypertension under Cesarean section in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020.Perioperative data were collected, including preoperative general condition, laboratory examination, auxiliary examination (blood routine, blood coagulation, liver and kidney function, electrocardiogram, cardiac ultrasound, etc.), perioperative indicators, postoperative laboratory examination (blood routine, blood coagulation, liver and kidney function, etc.), postoperative follow-up and satisfaction survey of patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • all women presenting for pregnancy-induced hypertension in Renji Hospital Affiliated to Shanghai Jiaotong University from January 2013 to January 2020 cesarean section operation

排除标准

  • 未提供

结局指标

主要结局

Adverse maternal outcomes

时间窗: 42 days after delivery

Adverse maternal outcomes were evaluated individually and as a composite and included number of acute kidney injury (serum creatinine \>1.1 mg/dL or oliguria), number of blood transfusion, number of eclampsia, rate of intensive care unit (ICU) admission, number of postpartum hemorrhage, or pulmonary edema.(From date of randomization until the date of discharged from hospital, whichever came first, assessed up to 40 weeks").

Adverse neonatal outcomes

时间窗: 42 days after delivery

Number of neonatal outcomes included preterm birth (PTB; \<37 weeks), Number of neonatal ICU (NICU) admission, number of neonatal intubation, and number of respiratory distress syndrome.(From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 40weeks).(From the date of birth until the date of discharged from hospital, whichever came first, assessed up to 5 weeks").

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验